Korea’s Financial Regulator To Investigate Celltrion CEO On Alleged Insider Trading, Stock Manipulation
This article was originally published in PharmAsia News
Executive Summary
The Financial Services Commission has asked state prosecutors to investigate Celltrion CEO Seo Jung-jin over alleged stock price manipulation, which is bad news for Seo who is looking to sell his stake in the biosimilars company.